Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Withdrawn 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 6 Sarcoma 3 Rhabdoid Tumor 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Melanoma 1 Medulloblastoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma 1 Inhibition, Psychological 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Hepatoblastoma 1 Glioma 1 Ependymoma 1 Chordoma 1

Interventions

Cyclophosphamide 26 Rituximab 22 Biopsy 17 Specimen Handling 16 Prednisone 15 Magnetic Resonance Spectroscopy 14 Doxorubicin 14 fludarabine 12 Vincristine 12 fludarabine phosphate 9 Etoposide 7 Bendamustine Hydrochloride 7 Tacrolimus 6 Nuclear Medicine Department, Hospital 6 Melphalan 6 trametinib 5 acalabrutinib 5 X-Rays 5 Whole-Body Irradiation 5 Radiotherapy 5 Mycophenolic Acid 5 Lenalidomide 5 Crizotinib 5 pembrolizumab 4 ibrutinib 4 copanlisib 4 Prednisolone 4 Mesna 4 Dexamethasone 4 Cytarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Lymphoma × tazemetostat × Clear all

NCT02889523 2024-10-09

Epi-RCHOP

The Lymphoma Academic Research Organisation

Phase 1/2 Active not recruiting

Lymphoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡